Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04545112

Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) — XABG-FIH  

Multi Vessel Coronary Artery Disease Clinical Trial

Official title:
Prospective, Non-randomized, First in Human (FIH) Clinical Study to Assess the Feasibility of the Novel Xeltis Coronary Artery Bypass Graft (XABG)

Clinical Trial Summary

A FIH study to collect preliminary device safety, feasibility and performance data of the XABG in patients with symptomatic coronary artery disease (SCAD), with suitable multi vessel disease (MVD) and selected by the local Heart Team for elective coronary artery bypass grafts surgery of at least 3 bypass grafts (minimally 1 artery and 2 veins or 2 arteries and 1 vein).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04545112
Study type Interventional
Source Xeltis
Contact
Status Enrolling by invitation
Phase N/A
Start date October 22, 2020
Completion date March 15, 2026
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06104033 - Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease
Recruiting NCT04968808 - Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) N/A
Active, not recruiting NCT05464147 - DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions N/A
Recruiting NCT05230446 - PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions N/A
Recruiting NCT05527717 - Revascularization Strategy of Multivessel Disease for Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator Phase 4
Completed NCT03455244 - Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel Disease
Completed NCT02546557 - Optilene® Suture for Coronary Artery Bypass Graft Surgery
Active, not recruiting NCT03424941 - The TransCatheter Valve and Vessels Trial N/A
Terminated NCT04252703 - 'MInimalist' or 'MOre Complete' Strategies for Revascularization in Octogenarians N/A
Completed NCT03252990 - 18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability
Completed NCT02325973 - Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI N/A
Completed NCT03138473 - Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of ACS Patients With Multi-Vessel Disease
Recruiting NCT03479593 - Culprit Lesions in NSTEMI With Multi Vessel Disease (NSTEMI-CULPRIT)
Completed NCT06039059 - Influence of Risk Factors on ISR and Nonintervened Lesions
Recruiting NCT06168968 - Multidisciplinary Approach to Reduce Cardiovascular Health Disparities
Recruiting NCT04918030 - STaged Interventional Strategies for Acute ST-seGment Elevation Myocardial Infarction Patient With Multi-vessel Disease（STAGED） N/A
Not yet recruiting NCT05166538 - Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery Bypass Phase 4
Active, not recruiting NCT03298659 - iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction N/A
Active, not recruiting NCT02943954 - FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction N/A
Not yet recruiting NCT03700645 - Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease Phase 4